These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 400390)
21. [Plasma renin activity and plasma aldosterone in essential hypertension: effect of age and diastolic blood pressure]. Vetter H; Alasso I; Appenheimer M; Weiand H; Stelkens H; Lucas R; Glänzer K; Witassek F; Stumpe KO; Trübestein G; Krück F Schweiz Med Wochenschr; 1976 Dec; 106(49):1729-32. PubMed ID: 1013695 [TBL] [Abstract][Full Text] [Related]
22. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis]. Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361 [No Abstract] [Full Text] [Related]
23. Propranolol, renin and hypertension: a review. Laragh JH; Bühler FR Postgrad Med J; 1976; 52 Suppl 4(604):109-15. PubMed ID: 787950 [TBL] [Abstract][Full Text] [Related]
24. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)]. Esch I; Placheta P; Gaul G Wien Klin Wochenschr; 1976 Jun; 88(13):415-8. PubMed ID: 824860 [TBL] [Abstract][Full Text] [Related]
25. [Controlled clinical study on 2 antialdosterone diuretics in the nephrotic syndrome]. Russo R; Schena FP; Colombo Pirola L Clin Ter; 1984 Apr; 109(1):23-9. PubMed ID: 6233076 [No Abstract] [Full Text] [Related]
26. [Saralasin in subjects with low renin arterial hypertension]. Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of K-canrenoate in post-surgical treatment of open heart paediatric surgery (author's transl)]. Capuani A; Bernabei M; Pasque A; Eufrate S G Ital Cardiol; 1980; 10(9):1148-55. PubMed ID: 7461364 [TBL] [Abstract][Full Text] [Related]
28. [Effect of canrenoate potassium on intraoperative disturbances of electrolyte equilibrium]. Eschner J; Fodor L; Ahnefeld FW Infusionsther Klin Ernahr; 1976 Apr; 3(2):98-104. PubMed ID: 965083 [TBL] [Abstract][Full Text] [Related]
29. [Potassium canreonate in neurosurgical brain edema]. Mille T; Rodriguez R; Baena Y Minerva Chir; 1975 Jul 15-31; 30(13-14):781-9. PubMed ID: 1221307 [TBL] [Abstract][Full Text] [Related]
30. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Angeli P; Dalla Pria M; De Bei E; Albino G; Caregaro L; Merkel C; Ceolotto G; Gatta A Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370 [TBL] [Abstract][Full Text] [Related]
31. [Urinary excretion of aldosterone in patients with hypertension]. Elenkova A; Grigorova R Vutr Boles; 1982; 21(5):69-74. PubMed ID: 6761962 [TBL] [Abstract][Full Text] [Related]
32. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction]. Denis B; Machecourt J; Denis MC; Morena H; Pellet J; Rossignol B; Martin-Noël P Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1014-22. PubMed ID: 116612 [TBL] [Abstract][Full Text] [Related]
33. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril]. Mazurek W; Halawa B; Borejko-Słopecka G Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334 [TBL] [Abstract][Full Text] [Related]
34. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
35. [Value of Soludactone in cardiac surgery in adults]. Fogliani J; Capuccio P; Goudard A; Guillen JC; Monties JR Ann Anesthesiol Fr; 1975; 16(3):189-96. PubMed ID: 241276 [TBL] [Abstract][Full Text] [Related]
36. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470 [TBL] [Abstract][Full Text] [Related]
37. [Study of the inotropic effect of potassium canrenoate by determining systolic time intervals]. Vitolo E; Gambini E; Larovere MT; Rusconi F; Vitali GM Boll Soc Ital Cardiol; 1979; 24(7):775-7. PubMed ID: 554665 [No Abstract] [Full Text] [Related]
38. [Potassium canrenoate and the combination of potassium canrenoate-butizide in the therapy of light to moderate arterial hypertension]. Morabito S; Fabiano M; Puliti M; Palumbo R; Marinelli R; Simonetti BM; Pierucci A Clin Ter; 1992 Jul; 141(7):23-8. PubMed ID: 1505173 [TBL] [Abstract][Full Text] [Related]
39. Essential arterial hypertension: plasma and urinary aldosterone alterations. Garcia Zozaya JL; Padilla Viloria M; Castro A South Med J; 1987 Oct; 80(10):1224-7. PubMed ID: 3310248 [TBL] [Abstract][Full Text] [Related]
40. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over. Emili M; Cuppone R; Ricci GL Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]